TrialScope, Inc. — Form D
TrialScope, Inc. of JERSEY CITY, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-25. The offering totals $4.0M, of which $3.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-04-25
- Form: D
- Accession: 0001192482-17-000107
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.6M
- Remaining: $400K
- Investors: 6
- Date of first sale: 2017-04-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-285468
Issuer
- Name: TrialScope, Inc.
- CIK: 0001610301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: Harborside 5, JERSEY CITY, NJ, 07311
- Phone: 212-937-8271
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| Michael A DiPiano | Director | Mt. Laurel, NJ |
| Mark Heinold | Director | Jersey City, NJ |
| James A Hill | Director | Princeton, NJ |
| Jeffrey C Kozloff | Director | Jersey City, NJ |
| Christopher C Noe | Director | Wayne, PA |
| Charles C Saldarini | Director | Jersey City, NJ |
| James C Walker | Director | Blue Bell, PA |
| Richard C Aguinaldo | Executive Officer | Jersey City, NJ |
| Mark Heinold | Executive Officer | Jersey City, NJ |
| Marc Lederman | Director | Radnor, PA |
| Michael Kopelman | Director | Philadelphia, PA |
| Jeffrey Kozloff | Director | Jersey City, NJ |
| Jeffrey Kozloff | Executive Officer | Jersey City, NJ |
| Matthew C Patras | Executive Officer | Jersey City, NJ |
| Larry C Berran | Director | Jersey City, NJ |
| Jim Michael Walker | Director | Jersey City, NJ |
| Eric Michael Jensen | Director | Radnor, PA |
| Joe Michael Stauffer | Director | Jersey City, NJ |
| Michael Michael Balmuth | Director | Lawrenceville, NJ |
| Chris Michael Noe | Director | King of Prussia, PA |
| E. Michael Forgash | Director | Jersey City, NJ |
| E. Michael Forgash | Executive Officer | Jersey City, NJ |
Other filings by this issuer (2)
More